| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/23/2001 | EP1100548A2 Genetically engineered cells and tissues |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100538A2 Kvlqt1 - a long qt syndrome |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100530A1 Use of glp-1 and analogues for preventing type ii diabetes |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100515A1 $i(EX VIVO) TREATMENT OF ALLOGENEIC AND XENOGENEIC T-CELLS WITH gp39 ANTAGONISTS |
| 05/23/2001 | EP1100429A2 Apoptosis proteins |
| 05/23/2001 | EP1100308A1 Copper transporter in ethylene signaling pathway |
| 05/23/2001 | EP0986533A4 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0215907B1 Parasite-derived resistance |
| 05/23/2001 | DE19955408A1 New invertebrate gamma-aminobutyric acid receptor proteins, useful in screening for potential insecticides, for plant protection or medicine, also related nucleic acid |
| 05/23/2001 | CN1296078A Recombination nucleic acid molecule and application thereof |
| 05/23/2001 | CN1296075A Humi grass cell engineering Seedling large-scale breeding technology |
| 05/23/2001 | CN1066198C Method for controlling plant pathogens |
| 05/22/2001 | US6235973 Expression of magainin and PGL classes of antimicrobial peptide genes in plants, and their use in creating resistance to multiple plant pathogens |
| 05/22/2001 | US6235970 CICM cells and non-human mammalian embryos prepared by nuclear transfer of a proliferating differentiated cell or its nucleus |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235968 Detecting angiogenesis |
| 05/22/2001 | US6235885 Central nervous system disorders |
| 05/22/2001 | US6235880 Polypeptides; hypoglycemic agent |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235529 Incubating barley tissue on callus-induction medium of auxin (dicamba and/or 2,4-dichlorophenoxyacetic acid) and copper compound to produce green regenerative tissue, transferring to regenerative medium and incubating to produce plant |
| 05/22/2001 | US6235527 Lineage restricted glial precursors from the central nervous system |
| 05/22/2001 | US6235526 Nucleic acid constructs containing genes encoding transport signals |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235522 Lentiviral vectors |
| 05/22/2001 | US6235515 Malathion carboxylesterase |
| 05/22/2001 | US6235513 IKK-α proteins, nucleic acids and methods |
| 05/22/2001 | US6235512 Nucleic acid encoding polypeptide of defined amino acid sequence which regulates transcription factor, nuclear factor kappa b, activation; hybridization probes and primers; antibodies; diagnosis; therapy |
| 05/22/2001 | US6235500 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 05/22/2001 | US6235498 Propagating mammalian aggregations; transform aggregates with nucleotide sequences which express insulin and heterologous polypeptide, propagate aggregates |
| 05/22/2001 | US6235496 Nucleic acid encoding mammalian mu opioid receptor |
| 05/22/2001 | US6235492 IKK-α proteins, nucleic acids and methods |
| 05/22/2001 | US6235480 Screening for the presence of target nucleotide sequences; incubate preferential nucleotide sequences with enzymes and screen for preferentially released nucleotides |
| 05/22/2001 | US6235316 Neocartilage and methods of use |
| 05/22/2001 | US6235263 Carboxy-terminal BRCA1 interacting protein |
| 05/22/2001 | CA2006709C Enzymatically active recombinant glucocerebrosidase |
| 05/22/2001 | CA1341236C Process for producing recombinant human factor viii: c and transformant to be used therefor |
| 05/17/2001 | WO2001034902A2 Process and composition for preparing a lignocellulose-based product, and the product obtained by the process |
| 05/17/2001 | WO2001034843A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | WO2001034833A2 Regulating endogenous inhibitor at atp synthase |
| 05/17/2001 | WO2001034825A1 Ptp/dna polymerase cell line as packaging cell line for minimal adenoviral vectors |
| 05/17/2001 | WO2001034824A2 Methods and compositions comprising renilla gfp |
| 05/17/2001 | WO2001034821A2 Chemical inducible promoter used to obtain transgenic plants with a silent marker and organisms and cells and methods of using same for screening for mutations |
| 05/17/2001 | WO2001034820A2 Chemical inducible promoters used to obtain transgenic plants with a silent marker |
| 05/17/2001 | WO2001034807A2 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor bt-r¿2? |
| 05/17/2001 | WO2001034805A2 Human vanilloid receptor gene |
| 05/17/2001 | WO2001034802A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | WO2001034801A2 Recombinant gelatin in vaccines |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034797A1 Method of preparing cell fraction containing hemangioblasts |
| 05/17/2001 | WO2001034786A1 Method for modulating nitrilase selectivity, nitrilases obtained by said method and use thereof |
| 05/17/2001 | WO2001034780A2 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | WO2001034776A1 Hematopoietic differentiation of human embryonic stem cells |
| 05/17/2001 | WO2001034775A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/17/2001 | WO2001034774A2 Method for protection of mammalian cells by means of over-expressed g-2/m cell cycle coupler |
| 05/17/2001 | WO2001034769A2 24 human secreted proteins |
| 05/17/2001 | WO2001034768A2 15 human secreted proteins |
| 05/17/2001 | WO2001034767A2 22 human secreted proteins |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034653A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | WO2001034647A2 Animal collagens and gelatins |
| 05/17/2001 | WO2001034646A2 Recombinant gelatins |
| 05/17/2001 | WO2001034644A1 15 human secreted proteins |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |
| 05/17/2001 | WO2001034640A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001034629A1 21 human secreted proteins |
| 05/17/2001 | WO2001034628A1 35 human secreted proteins |
| 05/17/2001 | WO2001034627A1 28 human secreted proteins |
| 05/17/2001 | WO2001034626A1 28 human secreted proteins |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001034206A2 Nucleic acid-containing complex |
| 05/17/2001 | WO2001034167A1 Isolation and expansion of human marrow stromal cells |
| 05/17/2001 | WO2001034166A1 Transplant/implant device and method for its production |
| 05/17/2001 | WO2001034091A2 Modification of polysaccharide containing materials |
| 05/17/2001 | WO2001033956A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033954A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033945A1 Stress-resistant oversized transgenic plants capable of growing in salinized soil |
| 05/17/2001 | WO2001023893A3 Detection of hla-g |
| 05/17/2001 | WO2001020003A3 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 05/17/2001 | WO2001019861A3 Apo-2 receptor antibodies |
| 05/17/2001 | WO2001018043A3 Neurogenic compositions and methods |
| 05/17/2001 | WO2001012598A9 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 05/17/2001 | WO2001009309A3 RESCUE OF MUMPS VIRUS FROM cDNA |
| 05/17/2001 | WO2001007891A3 Miniaturized cell array methods and apparatus for cell-based screening |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001002593A3 Control of gene expression in eukaryotic cells |
| 05/17/2001 | WO2000077166A3 Gene expression modulated in gastrointestinal inflammation |
| 05/17/2001 | WO2000071710A3 Expression products of genes involved in diseases related to cholesterol metabolism |
| 05/17/2001 | WO2000068414A3 Whole cell assay for cathepsin k |
| 05/17/2001 | WO2000049137B1 Pluripotential cell derived from an embryonic stem cell and a nucleus of a somatic cell |
| 05/17/2001 | WO2000033077A9 Cell matrix plaques of initial bone formation |